FDA Approves Unknown Drug — LANNETT CO INC
# FDA Approves ANDA for Lannett Co Inc Lannett Co Inc received FDA approval for ANDA077960 on October 13, 2006, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceutical sector. The approval strengthens Lannett's ability to meet demand for cost-effective alternative medications and reinforces its standing as a key player in the generic drug manufacturing industry.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day